These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34190517)

  • 21. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
    Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
    Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression.
    Sorrentino C; Miele L; Porta A; Pinto A; Morello S
    Oncotarget; 2016 Sep; 7(39):64274-64288. PubMed ID: 27590504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells.
    Gil M; Komorowski MP; Seshadri M; Rokita H; McGray AJ; Opyrchal M; Odunsi KO; Kozbor D
    J Immunol; 2014 Nov; 193(10):5327-37. PubMed ID: 25320277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NR2F1 contributes to cancer cell dormancy, invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12/CXCR4 pathway.
    Gao XL; Zheng M; Wang HF; Dai LL; Yu XH; Yang X; Pang X; Li L; Zhang M; Wang SS; Wu JB; Tang YJ; Liang XH; Tang YL
    BMC Cancer; 2019 Jul; 19(1):743. PubMed ID: 31357956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemokine receptor CXCR4 and its ligand CXCL12 expressions and clinical significance in bladder cancer.
    Yang DL; Xin MM; Wang JS; Xu HY; Huo Q; Tang ZR; Wang HF
    Genet Mol Res; 2015 Dec; 14(4):17699-707. PubMed ID: 26782415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression.
    Jiang YP; Wu XH; Shi B; Wu WX; Yin GR
    Gynecol Oncol; 2006 Oct; 103(1):226-33. PubMed ID: 16631235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expressions of stromal cell-derived factor-1 and CXCR4 in endometrial carcinoma tissues and cell lines].
    Li XP; Zhao D; Gao M; Wang JL; Wei LH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):458-62. PubMed ID: 17068613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXCL12 mediates immunosuppression in the lymphoma microenvironment after allogeneic transplantation of hematopoietic cells.
    Dürr C; Pfeifer D; Claus R; Schmitt-Graeff A; Gerlach UV; Graeser R; Krüger S; Gerbitz A; Negrin RS; Finke J; Zeiser R
    Cancer Res; 2010 Dec; 70(24):10170-81. PubMed ID: 21159639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer.
    Izumi D; Ishimoto T; Miyake K; Sugihara H; Eto K; Sawayama H; Yasuda T; Kiyozumi Y; Kaida T; Kurashige J; Imamura Y; Hiyoshi Y; Iwatsuki M; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Takamori H; Araki N; Tan P; Baba H
    Int J Cancer; 2016 Mar; 138(5):1207-19. PubMed ID: 26414794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer-associated fibroblast-derived CXCL12 causes tumor progression in adenocarcinoma of the esophagogastric junction.
    Sugihara H; Ishimoto T; Yasuda T; Izumi D; Eto K; Sawayama H; Miyake K; Kurashige J; Imamura Y; Hiyoshi Y; Iwatsuki M; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Takamori H; Baba H
    Med Oncol; 2015 Jun; 32(6):618. PubMed ID: 25920609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients.
    Katsura M; Shoji F; Okamoto T; Shimamatsu S; Hirai F; Toyokawa G; Morodomi Y; Tagawa T; Oda Y; Maehara Y
    Cancer Sci; 2018 Jan; 109(1):154-165. PubMed ID: 29032612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological blockage of the CXCR4-CXCL12 axis in endometriosis leads to contrasting effects in proliferation, migration, and invasion.
    Ruiz A; Ruiz L; Colón-Caraballo M; Torres-Collazo BJ; Monteiro JB; Bayona M; Fazleabas AT; Flores I
    Biol Reprod; 2018 Jan; 98(1):4-14. PubMed ID: 29161347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma.
    McConnell AT; Ellis R; Pathy B; Plummer R; Lovat PE; O'Boyle G
    Br J Dermatol; 2016 Dec; 175(6):1210-1220. PubMed ID: 27167239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression dynamics of CXCL12 and CXCR4 during the progression of mycosis fungoides.
    Daggett RN; Kurata M; Abe S; Onishi I; Miura K; Sawada Y; Tanizawa T; Kitagawa M
    Br J Dermatol; 2014 Oct; 171(4):722-31. PubMed ID: 24725174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of chemokine CXCL12 and its receptor CXCR4 on proliferation, migration and invasion of epithelial ovarian cancer cells].
    Jiang YP; Wu XH; Xing HY; DU XY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):403-7. PubMed ID: 17697603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemoattraction of bone marrow-derived stem cells towards human endometrial stromal cells is mediated by estradiol regulated CXCL12 and CXCR4 expression.
    Wang X; Mamillapalli R; Mutlu L; Du H; Taylor HS
    Stem Cell Res; 2015 Jul; 15(1):14-22. PubMed ID: 25957946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of CXCL12/CXCR4 in the motility of human first-trimester endometrial epithelial cells through an autocrine mechanism by activating PI3K/AKT signaling.
    Zheng J; Qu D; Wang C; Ding L; Zhou W
    BMC Pregnancy Childbirth; 2020 Feb; 20(1):87. PubMed ID: 32041571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXC receptor 4 and stromal cell-derived factor 1 in primary tumors and liver metastases of colorectal cancer.
    Yamada S; Shimada M; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Mori H; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y
    J Surg Res; 2014 Mar; 187(1):107-12. PubMed ID: 24238971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COUP-TFI modifies CXCL12 and CXCR4 expression by activating EGF signaling and stimulates breast cancer cell migration.
    Boudot A; Kerdivel G; Lecomte S; Flouriot G; Desille M; Godey F; Leveque J; Tas P; Le Dréan Y; Pakdel F
    BMC Cancer; 2014 Jun; 14():407. PubMed ID: 24906407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CXCR4 and CXCL12 Expression in Rectal Tumors of Stage IV Patients Before and After Local Radiotherapy and Systemic Neoadjuvant Treatment.
    Tamas K; Domanska UM; van Dijk TH; Timmer-Bosscha H; Havenga K; Karrenbeld A; Sluiter WJ; Beukema JC; van Vugt MA; de Vries EG; Hospers GA; Walenkamp AM
    Curr Pharm Des; 2015; 21(17):2276-83. PubMed ID: 25557636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.